Distribution of PD-1+ lymphocytes in reactive lymphadenopathies

Pathobiology

Volumn 77, Issue 1, 2010, Pages 24-27

  Muenst, Simone ^a   Dirnhofer, Stephan ^a   Tzankov, Alexandar ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angioimmunoblastic T cell lymphoma; PD 1; Reactive lymphadenopathies

Indexed keywords

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; GERMINAL CENTER; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIKUCHI DISEASE; LYMPHADENOPATHY; PRIORITY JOURNAL; ROSAI DORFMAN DISEASE; SARCOIDOSIS; SKIN DISEASE; T CELL LYMPHOMA; T LYMPHOCYTE;

ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; GIANT LYMPH NODE HYPERPLASIA; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHATIC DISEASES; LYMPHOCYTES; SARCOIDOSIS;

EID: 77749328948     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000272951     Document Type: Article

References (11)

1. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ: Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006; 30: 802-810.
2. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M: Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005; 6: 280-286.
3. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2: 261-268.
4. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682-687.
5. Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T: Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007; 92: 1059-1066.
6. Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA: Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 2009; 22: 753-761.
7. Shahidi H, Myers JL, Kvale PA: Castleman's disease. Mayo Clin Proc 1995; 70: 969-977.
8. Casper C: The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005; 129: 3-17.
9. Rowland-Jones S, Dong T: HIV: tired T cells turn around. Nature 2006; 443: 282-283.
10. De Milito A: B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004; 2: 11-21.
11. Grunewald J, Eklund A: Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 2007; 4: 461-464.